ESR1 and neoplasm: More complex models representing ER+ cancer are becomingavailable, in the form of patient-derived xenograft (PDX) tumours, which providenumerous additional models for the investigation of ER+ disease, althoughthe primary tumours that typically engraft in mice, such as PDX tumours, tend to bethe more aggressive ER+ cancers (66).